A study has shown that the number of pathogenic IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ Th17 cell subsets is negatively regulated by intestinal HLA-DR-expressing-NKp44+-ILC3s in IBD patients [44]. The gene discussed is IFNG; the disease is inflammatory bowel disease.